Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

July 10, 2020

Progression and survival of patients with motor neuron disease relative to their fecal microbiota

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Shyuan T NgoFrederik J Steyn
July 7, 2020

Anti-aging Klotho Protects SH-SY5Y Cells Against Amyloid β1-42 Neurotoxicity: Involvement of Wnt1/pCREB/Nrf2/HO-1 Signaling

Journal of Molecular Neuroscience : MN
Mohsen SedighiMehrdad Roghani
July 7, 2020

Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging

Neurobiology of Aging
Begün ErbabaAyça Arslan-Ergül
July 3, 2020
Review

Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Adam B EdwardsBruno P Meloni
June 27, 2020
Open Access

Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells

Scientific Reports
Prashant BharadwajPhilip Newsholme
July 1, 2020

Reassembly of the biosynthetic gene cluster enables high epothilone yield in engineered Schlegelella brevitalea

ACS Synthetic Biology
Yucong YuXiaoming Ding
July 2, 2020
Open Access

Insights into lncRNAs in Alzheimer's Disease Mechanisms

RNA Biology
Dingfeng LiQiang Liu
July 8, 2020

Analysis of global gene expression at seven brain regions of patients with schizophrenia

Schizophrenia Research
Paweł KarpińskiBłażej Misiak
July 2, 2020
Preprint
Open Access

Non-allelic homologous recombination of Alu and LINE-1 elements generates somatic complexity in human genomes.

BioRxiv : the Preprint Server for Biology
G. PascarellaPiero Carninci
July 1, 2020

Recent advances on the role of long non-coding RNAs in Alzheimer's disease

Neural Regeneration Research
Kyle DoxtaterMohammad Moshahid Khan
July 2, 2020

Plasma proteomic signatures predict dementia and cognitive impairment

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Toshiko TanakaLuigi Ferrucci
July 1, 2020

Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia

Journal of Alzheimer's Disease : JAD
Leonie J M VergouwVincenzo Bonifati
July 1, 2020

Spinocerebellar Ataxia-Like Presentation of the M233V PSEN1 Mutation

The Cerebellum
Yury SeliverstovSergey Illarioshkin
July 4, 2020

Frontotemporal dementia: Plasma metabolomic signature using gas chromatography-mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis
Anna Luiza Morais SantosKarina Braga Gomes

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-sequencing/34563c7f-8cf6-4c83-aa4a-c983916648d6